1,3-Dipolar Cycloaddition of Diazoalkanes
MHz) δ 0.85 (d, 3H, J ) 7.2 Hz), 1.58-1.70 (m, 1H), 2.24-2.30
(m, 2H), 2.41 (s, 3H), 4.13 (ddd, 1H, J ) 3.3, 5.7, and 11.4 Hz),
4.38 (m, 2H), 7.33 and 7.47 (AA′BB′ system, 4H); 13C NMR
(CDCl3, 75 MHz) δ 16.5, 21.5, 27.8, 33.8, 66.6, 93.5,113.2, 126.6,
129.5, 135.4, 143.7, 162.5; EIMS m/z 278 (7%, M+ - 14), 264
(44), 152 (29), 139 (100), 125 (38), 91 (47), 53 (25).
B. Extrusion of Nitrogen from Pyrazolines 4-7-exo under
Lewis Acid Catalyst. To a solution of Yb(OTf)3 (0.056 g, 0.09
mmol) in THF (2 mL) under argon was added a solution of
pyrazolines 4-7-exo (0.18 mmol) in THF (3 mL). The mixture
was stirred at the temperature and time indicated in Table 3. Then,
the reaction was quenched with aqueous saturated potassium sodium
tartrate at the indicated temperature and extracted with CH2Cl2 (3
× 10 mL). The extracts were washed with brine and dried. The
solvent was removed under vacuum and purified as indicated in
each case.
(1R,6R,SS)-1-[(4-Methylphenyl)sulfinyl]-3-oxabicyclo[4.1.0]-
heptan-2-one (8). Compound 8 was obtained from 4 (entry 3 in
Table 3) and was purified by flash chromatography (ethyl
acetate-hexane 80:20): white crystals (66% yield), mp 140-143
°C; [R]20D +79.8 (c 0.5, acetone); IR (KBr) νmax 1709, 1119, 1041
cm-1; 1H NMR (CDCl3, 300 MHz) δ 1.73-1.84 (m, 1H), 1.81 (t,
1H, J ) 6.3 Hz), 1.85 (dd, 1H, J ) 6.3 and 8.7 Hz), 1.97-2.05
(m, 1H), 2.27-2.34 (m, 1H), 4.01-4.16 (m, 2H), 7.28 and 7.61
(AA′BB′ system, 4H); 13C NMR (CDCl3, 75 MHz) δ 13.4, 14.3,
20.5, 21.4, 43.2, 64.3, 125.1, 129.7, 139.3, 142.1, 167.7; EIMS m/z
250 (100%, M+), 234 (3), 222 (9), 139 (72), 111 (16), 92 (34), 53
(15); HRMS (FAB+) m/z calcd for C13H15O3S [M + 1] 251.0742,
found 251.0740.
C. Reaction of Pyrazolines 4-7-exo with m-CPBA.
Method A. To a solution of pyrazoline 4 or 5 (0.05 g, 0.18 mmol)
in 5 mL of CH2Cl2 at 0 °C was added a solution of m-CPBA (0.062
g 0.36 mmol) in 5 mL of CH2Cl2. The mixture was stirred at 0 °C
for 24 h. Then a 10% solution of Na2CO3 was added, and the
mixture was extracted with CH2Cl2 (3 × 10 mL). The organic
extracts were dried with Na2SO4 and concentrated. The residue was
dissolved in THF (5 mL), and Yb(OTf)3 (0.039 g, 0.063 mmol)
was added. The mixture was stirred at room temperature for 5 min,
quenched with aqueous saturated potassium sodium tartrate, and
extracted with CH2Cl2 (3 × 10 mL). The extracts were dried with
Na2SO4, concentrated, and purified by crystallization from Et2O.
Method B. To a solution of pyrazoline 6-exo (0.037 g, 0.13
mmol) or 7-exo (0.025 g, 0.086 mmol) in 5 mL of CH2Cl2 at room
temperature was added a solution of m-CPBA (2 equiv) in 4 mL
of CH2Cl2. The mixture was stirred at room temperature for 19 h.
Then a 10% solution of Na2CO3 was added, and the mixture was
extracted with CH2Cl2 (3 × 10 mL). The organic extracts were
dried with Na2SO4 and concentrated. The residue was purified by
flash chromatography (ethyl acetate-hexane 60:40).
(1R,6R)-1-[(4-Methylphenyl)sulfonyl]-3-oxabicyclo[4.1.0]heptan-
2-one (16). Compound 16 was obtained from 4 by method A (entry
2 in Table 4): white solid (100% yield), mp 142 °C (d); [R]20
D
-42.8 (c 0.25, acetone); IR (KBr) νmax 2931, 1727, 1302, 1154
1
cm-1; H NMR (CDCl3, 300 MHz) δ 1.87 (t, 1H, J ) 6.6 Hz),
2.03-2.11 (m, 2H), 2.24-2.36 (m, 1H), 2.44 (s, 3H), 2.84-2.91
(m, 1H), 4.07 (dt, 1H, J ) 3.6 and 12 Hz), 4.23-4.30 (m, 1H),
7.33 and 7.91 (AA′BB′ system, 4H); 13C NMR (CDCl3, 75 MHz)
δ 16.0, 20.7, 21.6, 22.5, 44.1, 64.9, 129.4, 129.6, 136.1, 144.9,
163.9; EIMS m/z 267 (1%, M+), 202 (24), 187 (37), 157 (61), 143
(27), 91 (100), 65 (46), 53 (45), 41 (48); HRMS (FAB+) m/z calcd
for C13H15O4S [M + 1] 267.0691, found 267.0692.
(1S,6S,SS)-1-[(4-Methylphenyl)sulfinyl]-3-oxabicyclo[4.1.0]-
heptan-2-one (9). Compound 9 was obtained from 5 (entry 4 in
Table 3) and was purified by flash chromatography (ethyl
(1S,6S)-1-[(4-Methylphenyl)sulfonyl]-3-oxabicyclo[4.1.0]heptan-
2-one (ent-16). Compound ent-16 was obtained from 5 by method
acetate-hexane 80:20): opaque oil (65% yield); [R]20 +120 (c
D
A (entry 3 in Table 4): white solid (95% yield); [R]20 +40.4 (c
1
0.5, acetone); IR (film) νmax 1715, 1121, 1015 cm-1; H NMR
D
0.25, acetone). The spectroscopic data were identical to those
compound 16.
(CDCl3, 300 MHz) δ 1.48 (dd, 1H, J ) 6.3 and 9.0 Hz), 1.63 (t,
1H, J ) 6.6 Hz), 2.07-2.13 (m, 1H), 2.27 (ddt, 1H, J ) 3.3, 6.0,
and 14.7 Hz), 2.40 (s, 3H), 2.51 (m, 1H), 4.07 (dt, 1H, J ) 3.3 and
12.0 Hz), 4.29-4.35 (m, 1H), 7.29 and 7.74 (AA′BB′ system, 4H);
13C NMR (CDCl3, 75 MHz) δ 10.0, 20.4, 21.3, 21.4, 43.4, 64.4,
125.3, 129.5, 139.9, 141.7, 168.3; EIMS m/z 250 (100%, M+), 234
(3), 222 (9), 139 (91), 111 (20), 92 (41), 53 (24); HRMS (FAB+)
m/z calcd for C13H15O3S [M + 1] 251.0742, found 251.0737.
(1R,6R,7R,SS)-7-Methyl-1-[(4-methylphenyl)sulfinyl]-3-oxabi-
cyclo[4.1.0]heptan-2-one (10). Compound 10 was obtained from
6-exo (entry 13 in Table 3) and was purified by flash chromatog-
raphy (ethyl acetate-hexane 80:20): white crystals (37% yield),
mp 151-152 °C; [R]20D +142 (c 0.5, acetone); IR (KBr) νmax 1706,
1282, 1042 cm-1; 1H NMR (CDCl3, 300 MHz) δ 1.54 (d, 1H, J )
6.3 Hz), 1.89-2.07 (m, 3H), 2.39 (s, 3H), 2.57-2.62 (m, 1H), 7.27
and 7.65 (AA′BB′ system, 4H); 13C NMR (CDCl3, 75 MHz) δ 10.6,
18.5, 21.3, 21.4, 25.6, 47.1, 65.9, 126.1, 129.6, 140.3, 142.4, 166.9;
EIMS m/z 264 (74%, M+), 216 (8), 140 (45), 125 (100), 92 (41),
79 (24), 67(24), 41 (25); HRMS (FAB+) m/z calcd for C14H17O3S
[M + 1] 265.0898, found 265.0895.
(1R,6R,7R)-7-Methyl-1-[(4-methylphenyl)sulfonyl]-3-oxabicy-
clo[4.1.0]heptan-2-one (17). Compound 17 was obtained from
6-exo by method B (entry 4 in Table 4): white solid (65% yield),
mp 137-139 °C; [R]20D -18.4 (c 0.5, CHCl3); IR (KBr) νmax 2930,
1
1733, 1309, 1150 cm-1; H NMR (CDCl3, 300 MHz) δ 1.60 (d,
3H, J ) 6.6 Hz), 1.97 (dq, 1H, J ) 6.3 and 6.6 Hz), 1.93-2.08
(m, 1H), 2.28 (ddd, 1H, J ) 5.1, 9.6, and 19.5 Hz), 2.74-2.79 (m,
1H), 4.14 (ddd, 1H, J ) 4.2, 9.0, and 11.7 Hz), 4.22-4.29 (m,
1H), 7.33 and 7.93 (AA′BB′ system, 4H); 13C (CDCl3, 75 MHz) δ
11.6, 21.6, 21.8, 48.1, 66.6, 129.3, 129.4, 136.9, 144.8, 164.3; EIMS
m/z 281 (1%, M+), 215 (23), 201 (71), 125 (100), 91 (40), 79 (26),
67 (25), 41 (24).
(1S,6S,7S)-7-Methyl-1-[(4-methylphenyl)sulfonyl]-3-oxabicy-
clo[4.1.0]heptan-2-one (ent-17). Compound ent-17 was obtained
from 7-exo by method B (entry 5 in Table 4): white solid (65%
yield); [R]20 +18.2 (c 0.5, CHCl3). The spectroscopic data were
D
identical to those compound 17.
Conclusions
(1S,6S,7S,SS)-7-Methyl-1-[(4-methylphenyl)sulfinyl]-3-oxabi-
cyclo[4.1.0]heptan-2-one (11). Compound 11 was obtained from
7-exo (entry 14 in Table 3) and was purified by flash chromatog-
raphy (ethyl acetate-hexane 80:20): white crystals (35% yield),
mp 184-186 °C; [R]20D +53.8 (c 0.5, acetone); IR (KBr) νmax 1706,
We have provided a new and efficient methodology for
preparing enantiomerically pure 3-oxabicyclo[4.1.0]heptan-2-
ones by almost complete stereoselective reactions of (S)-(+)-
3-[(4-methylphenyl)sulfinyl]-5,6-dihydropyran-2-one (3) with
diazoalkanes and subsequent treatment with Yb(OTf)3. Sulfinyl
pyrazolines afforded mixtures of cyclopropanes and olefins,
whereas from sulfonyl pyrazolines, cyclopropanes are exclu-
sively obtained in better yields. This behavior provides evidence
for the relationship between the magnitude of the electron-
withdrawing character of the substituents on the pyrazoline ring
and the ease of the conversion thereof into cyclopropanes.
1
1277, 1137, 1028 cm-1; H NMR (CDCl3, 300 MHz) δ 1.04 (d,
3H, J ) 6.3 Hz), 2.06-2.14 (m, 2H), 2.17-2.25 (m, 1H), 2.29 (q,
1H, J ) 6.6 Hz), 2.40 (s, 3H), 4.13 (dt, 1H, J ) 3.9 and 12.0 Hz),
4.24-4.31 (m, 1H), 7.28 and 7.78 (AA′BB′ system, 4H); 13C NMR
(CDCl3, 75 MHz) δ 11.3, 20.2, 21.3, 26.2, 46.4, 65.6, 125.4, 129.5,
139.3, 140.7, 167.8; EIMS m/z 264 (70%, M+), 216 (7), 140 (50),
125 (100), 92 (42), 79 (21), 67 (30), 41 (26); HRMS (FAB+) m/z
calcd for C14H17O3S [M + 1] 265.0898, found 265.0899.
J. Org. Chem. Vol. 74, No. 10, 2009 3825